2020
article
OpenAlex
Pierre Frange, Roland Tubiana, Jeanne Sibiude, Ana Canestri et autres
BACKGROUND: Safety data about rilpivirine use during pregnancy remain scarce, and rilpivirine plasma concentrations are reduced during second/third trimesters, with a potential risk of viral breakthroughs. Thus, French guidelines recommend switching to rilpivirine-free combinations (RFCs) during pregnancy. OBJECTIVES: To describe the characteristics …
fr, gb
(code pays fourni par la source)
2015
article
OpenAlex
Laurent Mandelbrot, Roland Tubiana, Jerome Le Chenadec, Catherine Dollfus et autres
BACKGROUND: The efficacy of preventing perinatal transmission (PT) of human immunodeficiency virus type 1 (HIV-1) depends on both viral load (VL) and treatment duration. The objective of this study was to determine whether initiating highly active antiretroviral therapy (ART) before conception has …
fr, us
(code pays fourni par la source)
Accès ouvert
2014
article
OpenAlex
Clément Taron-Brocard, Jérôme Le Chenadec, Albert Faye, Catherine Dollfus et autres
BACKGROUND: Morbidity and mortality are higher among human immunodeficiency virus (HIV) exposed but uninfected (HEU) infants than unexposed infants, particularly if the mother had a low CD4 count. We investigated the possible association between maternal immune depression during pregnancy and the risk …
fr, be
(code pays fourni par la source)